FindTrial
Sign In

Multicenter randomized split-face controlled trial on laser treatment for xanthelasma palpebrarum

Multicenter randomized split-face controlled trial on laser treatment for xanthelasma palpebrarum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009561
Enrollment
Unknown
Registered
2016-10-23
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xanthelasma palpebrarum

Interventions

Control Group:Fractional CO2 laser
Group A:Ultra pulse CO2 laser
Group B:Q-switch 1064nm laser
Group C:Fractional Er-YAG laser

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. Clinical diagnosis of xanthelasma palpebrarum; 3. Xanthelasma lesions are bilaterally symmetric; 4. Have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Received other treatments, which may have some influence on the evaluation of efficacy; 2. Scar diathesis; 3. Obvious evidence of sun-tanning recently; 4. Photosensitivity or in the past two weeks, has taken medications that may cause photosensitivity; 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Response rate;—

Countries

China

Contacts

Public ContactYi Zhao

Beijing Tsinghua Changgung Hospital

zhaoyimd@mail.tsinghua.edu.cn+86 10 56119127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026